|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1996-9-17
|
|
pubmed:abstractText |
Advanced pancreatic adenocarcinoma is a rapidly fatal disease for which an active chemotherapy regimen is sought. Here we report the outcome of a phase II trial to assess the toxicity and efficacy of a combination of 5-fluorouracil (5-FU), leucovorin and cisplatin (CDDP).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
173-8
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8777174-Adenocarcinoma,
pubmed-meshheading:8777174-Adult,
pubmed-meshheading:8777174-Aged,
pubmed-meshheading:8777174-Aged, 80 and over,
pubmed-meshheading:8777174-Antidotes,
pubmed-meshheading:8777174-Antimetabolites, Antineoplastic,
pubmed-meshheading:8777174-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8777174-Cisplatin,
pubmed-meshheading:8777174-Female,
pubmed-meshheading:8777174-Fluorouracil,
pubmed-meshheading:8777174-Humans,
pubmed-meshheading:8777174-Leucovorin,
pubmed-meshheading:8777174-Male,
pubmed-meshheading:8777174-Middle Aged,
pubmed-meshheading:8777174-Palliative Care,
pubmed-meshheading:8777174-Pancreatic Neoplasms,
pubmed-meshheading:8777174-Prospective Studies,
pubmed-meshheading:8777174-Survival Rate,
pubmed-meshheading:8777174-Treatment Outcome
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma.
|
|
pubmed:affiliation |
Department of Medical Oncology, Tenon Hospital, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
